Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Ann Endocrinol (Paris) ; 73(1): 37-42, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22265326

RESUMEN

Von Hippel-Lindau disease is an autosomal dominant disorder involving the development of specific tumours in multiple organs, both benign and malignant. In the CNS, the syndrome is characterized by haemangioblastomas of the retina, spinal cord and brain. We report the case of a 15-year-old boy with the diagnosis of aggressive GH-PRL pituitary macroadenoma and a family history of VHL disease. Pituitary resection was performed, although complete excision of the lesion could not be confirmed by the neurosurgeon. A control MRI was done 6 months after surgery and the pituitary lesion was similar to the presurgical image. A second operation allowed partial resection of the tumour followed by targeted radiotherapy. Pituitary adenomas are rare benign tumours in children with macroadenomas observed mainly in boys. These tumours in adolescents often occur in a familial setting or in the context of known genetic defects. Angiogenesis is an important feature of pituitary adenomas and a possible inhibitory role of pVHL in pituitary angiogenesis has been suggested. This GH-PRL pituitary macroadenoma with a VHL mutation might be of particular aggressiveness. Pituitary adenomas are not classically described in VHL syndrome and the medical community should be alerted to its rare occurrence in this location.


Asunto(s)
Adenoma/genética , Mutación , Neoplasias Hipofisarias/genética , Proteína Supresora de Tumores del Síndrome de Von Hippel-Lindau/genética , Enfermedad de von Hippel-Lindau/genética , Adenoma/tratamiento farmacológico , Adenoma/patología , Adenoma/radioterapia , Adenoma/cirugía , Adolescente , Antineoplásicos/uso terapéutico , Cabergolina , Ergolinas/uso terapéutico , Hormona de Crecimiento Humana/sangre , Humanos , Imagen por Resonancia Magnética , Masculino , Neoplasias Hipofisarias/tratamiento farmacológico , Neoplasias Hipofisarias/patología , Neoplasias Hipofisarias/radioterapia , Neoplasias Hipofisarias/cirugía , Prolactina/sangre , Somatostatina/uso terapéutico , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...